A young specialist explores a paradigm shift in the cyclical 'treat, respond, relapse, repeat' approach to therapy for ...

Finally, hematopoietic stem cell transplantation ... Therapeutic options for relapsed follicular lymphoma include the same traditional regimens used for first-line therapy; however, they also ...

Follicular lymphoma -- typically ... bendamustine plus rituximab was evaluated as a first-line treatment for indolent non-Hodgkin lymphoma or mantle cell lymphoma compared with a standard ...

CAR T-cell therapy is an effective treatment for aggressive subtypes of follicular lymphoma, according to a clinical trial published in Nature Medicine. A team led by researchers at Weill Cornell ...

including 8 with diffuse large B-cell lymphoma, 2 with transformed follicular lymphoma, 1 with high-grade B-cell lymphoma, and 1 with T-cell histiocyte-rich B-cell lymphoma; 6 patients had ...

Four years after remission from follicular lymphoma, ongoing fear of relapse, lingering symptoms, and life stressors continue ...

Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a malignancy where the first-generation drug ibrutinib (Imbruvica) failed.

Watchful waiting—also known as active surveillance—is a common approach for asymptomatic, advanced stage follicular lymphoma, ...

During a live event, Krish Patel, MD, surveyed participants on using bispecific T-cell engagers vs loncastuximab in a patient ...

The new first-line MCL indication gives Calquence ... including CLL, MCL, follicular lymphoma, and diffuse large B-cell lymphoma (DLBCL).